MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancer.
Jing ChenJing YangYufang LiuXu ZhaoJuanjuan ZhaoLin TangMengmeng GuoYa ZhouChao ChenDongmei LiZhenke WenGuiyou LiangLin XuPublished in: Cancer innovation (2024)
Our results reveal that MAPK4 plays an important role in the angiogenesis and development of NSCLC. MAPK4 may thus represent a new target for NSCLC.